APOA1 anticorps
-
- Antigène Voir toutes APOA1 Anticorps
- APOA1 (Apolipoprotein A-I (APOA1))
-
Reactivité
- Humain
-
Hôte
- Souris
-
Clonalité
- Monoclonal
-
Conjugué
- Cet anticorp APOA1 est non-conjugé
-
Application
- Western Blotting (WB), ELISA
- Purification
- purified
- Immunogène
- Purified recombinant fragment of human APOA1 expressed in E. coli.
- Clone
- 5F4F5
- Isotype
- IgG1
- Top Product
- Discover our top product APOA1 Anticorps primaire
-
-
- Indications d'application
- ELISA: 1:10000, WB: 1:500 - 1:2000
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- Ascitic fluid containing 0.03 % sodium azide.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- 4 °C/-20 °C
- Stockage commentaire
- 4°C, -20°C for long term storage
-
-
The contribution of individual and pairwise combinations of SNPs in the APOA1 and APOC3 genes to interindividual HDL-C variability." dans: Journal of molecular medicine (Berlin, Germany), Vol. 84, Issue 7, pp. 561-72, (2006) (PubMed).
: "Short-term dehydroepiandrosterone treatment increases platelet cGMP production in elderly male subjects." dans: Clinical endocrinology, Vol. 64, Issue 3, pp. 260-4, (2006) (PubMed).
: "
-
The contribution of individual and pairwise combinations of SNPs in the APOA1 and APOC3 genes to interindividual HDL-C variability." dans: Journal of molecular medicine (Berlin, Germany), Vol. 84, Issue 7, pp. 561-72, (2006) (PubMed).
-
- Antigène
- APOA1 (Apolipoprotein A-I (APOA1))
- Autre désignation
- APOA1 (APOA1 Produits)
- Synonymes
- anticorps Alp-1, anticorps Apoa-1, anticorps Brp-14, anticorps Ltw-1, anticorps Lvtw-1, anticorps Sep-1, anticorps Sep-2, anticorps Sep2, anticorps apoA-I, anticorps apoa, anticorps apoa1, anticorps cb49, anticorps wu:fb33f01, anticorps zgc:103718, anticorps MGC64335, anticorps MGC89745, anticorps Apo-AI, anticorps ApoA-I, anticorps APOA1, anticorps LOC100136573, anticorps apoa-i, anticorps ApoAI, anticorps apolipoprotein A1, anticorps apolipoprotein A-I, anticorps apolipoprotein A-Ia, anticorps apolipoprotein A-I S homeolog, anticorps apolipoprotein A4, anticorps APOA1, anticorps Apoa1, anticorps apoa1a, anticorps apoa1.S, anticorps apoa1, anticorps LOC100136573, anticorps apoa-i, anticorps apoa4
- Sujet
-
Description: APOA1: apolipoprotein A-I, it is the major protein component of high density lipoprotein (HDL) in plasma. The protein promotes cholesterol efflux from tissues to the liver for excretion, and it is a cofactor for lecithin cholesterolacyltransferase (LCAT) which is responsible for the formation of most plasma cholesteryl esters. Defects in the Apolipoprotein A I gene are associated with HDL deficiency and Tangier disease. The therapeutic potential of apoA-I has been recently assessed in patients with acute coronary syndromes, using a recombinant form of a naturally occurring variant of apoA-I. The availability of recombinant normal apoA-I should facilitate further investigation into the potential usefulness of apoA-I in preventing atherosclerotic vascular diseases.
Aliases: MGC117399
- Poids moléculaire
- 25 kDa
- ID gène
- 335
- HGNC
- 335
- Pathways
- Regulation of Lipid Metabolism by PPARalpha, Production of Molecular Mediator of Immune Response, Lipid Metabolism
-